These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29654809)

  • 1. Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships.
    Starr CG; Maderdrut JL; He J; Coy DH; Wimley WC
    Peptides; 2018 Jun; 104():35-40. PubMed ID: 29654809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide.
    Debbabi S; Groleau MC; Létourneau M; Narayanan C; Gosselin LL; Iddir M; Gagnon J; Doucet N; Déziel E; Chatenet D
    PLoS One; 2018; 13(11):e0207366. PubMed ID: 30462698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
    Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M
    Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs.
    Naruse S; Suzuki T; Ozaki T
    Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    Margiotta JF; Pardi D
    Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
    Braas KM; Brandenburg CA; May V
    Endocrinology; 1994 Jan; 134(1):186-95. PubMed ID: 8275932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel stable PACAP analogs with potent activity towards the PAC1 receptor.
    Bourgault S; Vaudry D; Botia B; Couvineau A; Laburthe M; Vaudry H; Fournier A
    Peptides; 2008 Jun; 29(6):919-32. PubMed ID: 18353507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).
    Miyata A; Jiang L; Dahl RD; Kitada C; Kubo K; Fujino M; Minamino N; Arimura A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):643-8. PubMed ID: 2383262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.